Connect with us

Government

Celebrity views on COVID-19 aren’t welcome — except when drawing attention to heroes

Celebrity views on COVID-19 aren’t welcome — except when drawing attention to heroes

Published

on

Julia Roberts interviewed Dr. Anthony Fauci for a non-profit organization. Here, Roberts, left, at an Obama Foundation event in December 2019, and Fauci, right, in Washington on June 23. (AP Photo/Vincent Thian and Sarah Silbiger/Pool via AP)

On July 1, the One Campaign, a global anti-poverty organization co-founded by uber-celebrity-activist Bono, announced that its #PassTheMic campaign had ended successfully. Over the past two months, celebrities teamed up for online discussions about COVID-19 with scientific experts who were then invited to take over their social media accounts. In so doing, they leveraged the attention-getting cultural power of celebrity to circulate reliable information about the pandemic.

Julia Roberts went first, with a widely viewed and publicized discussion with the man she called a “personal hero”: Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, arguably a celebrity in his own right. But most of the guests hosted were not household names.

Celebrities, who are defined by their hoarding of cultural attention, are only effective or welcome in the current global health crisis, it would appear, when they forgo their attention-seeking natures and instead direct the spotlight elsewhere.

We saw this early in the pandemic when some celebrities tried to comment on the crisis in their usual, attention-getting ways — and failed.

Julia Roberts interviews Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases.

Painful video

As a scholar who has spent years studying the cultural politics of celebrity, I can pinpoint when the broader public began to turn on celebrities during the pandemic and derided them.

It was March 18, not long after most of the United States had shut down. Actor Gal Gadot turned on a camera, sighed over being a whole six days in isolation, and began to sing the first line of John Lennon’s “Imagine.” The camera then cut to a sequence of celebrity friends (Kristen Wiig, Mark Ruffalo, Jimmy Fallon …. ) each singing a line of the song from their various socially isolated locations.

Jon Caramanica, pop music critic at the New York Times, panned the performance for being full of “smug self-satisfaction,” as well as for its lack of musicality. He tartly observed: “It is proof that even if no one meets up in person, horribleness can spread.”

The video prompted a series of stories asking whether the coronavirus had “shattered our fame obsession” and identifying the “other COVID-19 outbreak: loopy celebrity quarantine videos.”

Madonna, a few days later, gave media analysts and consumers fresh material for derision when she took to her petal-strewn, candle-encircled bath to tell us that coronavirus is “the great equalizer.”

Just like us?

It’s worth looking at why these videos fell so flat and struck a sour note both politically and musically. Such efforts failed to balance their privileged status with performed “ordinariness” that has been at the heart of celebrity representations of self for many years.

Maintaining celebrity is often a matter of projecting an air of ordinariness that might legitimize the star’s special status by pleading that they are, after all, “just like us.”

But the spectacle of wealthy celebrities performing a song that exhorts us to “imagine no possessions,” while not making any demonstrable material contribution to the fight against COVID-19, struck many viewers as vainly self-serving and desperately out of touch with the struggles of many people.

The balancing of ordinariness and privilege has always been a fragile act of public relations. When the Hollywood studio system was in full sway, publicity departments were aware of the power of ordinariness. For example, publicists let it be known that child star Judy Garland loved playing baseball, and they produced photographs to support this evidence of healthy, ordinary American girlhood. But Garland’s childhood, as we now know, was far from ordinary or healthy.

More recently, stars or their publicists perform this ordinariness through social media, but the public’s approval hangs in a precarious balance. Julia Roberts’s conversation with Fauci avoids the “Imagine” effect partly because it is directed to specific beneficial actions.

After 9/11

But we have been here before: in the days following 9/11, celebrity came under renewed scrutiny and even derision.

As the Australian celebrity studies scholar David Marshall recalls, after the Twin Towers fell, there followed a month of “the new sobriety,” during which “celebrity represented everything that was excessively insignificant,” but it amounted to little more than a “temporary chastising blip.”

When challenges like this confront the celebrity system, like most systems, it adapts.

In the days following 9/11, Marshall notes, stars like George Clooney and Tom Hanks publicly praised first responders, whom they characterized as the real stars. Clooney was part of organizing the “America: Tribute to Heroes” fundraising concert and Hanks, speaking at it, declared, speaking of himself and other celebrity artists: “Those of us here tonight are not heroes.”

This is the performative mode that I call “reluctant celebrity,” when the celebrity expresses a disinclination to be a highly visible public individual, turning attention elsewhere as a means of, paradoxically, hanging on to that public visibility.

Neil Young performs John Lennon’s ‘Imagine’ at ‘A Tribute to Heroes’ concert in 2001.

And to a great degree, in America post-9/11, it worked.

But now? Things are different.

In this together?

The virus has discredited the primary narrative: “We are all in this together.” That narrative was more convincing to many Americans in the autumn of 2001, even though that crisis exacerbated social inequity, particularly for American Muslims: in 2016, public health research reported that hate crimes against Muslims in the U.S. were five times more common than before 9/11.

Still, a broad audience could find Neil Young’s performance of “Imagine” at the “America: Tribute to Heroes” concert in 2001 appropriate and moving, given how its lyrics readily suggested a call to reject racist and violent responses to the attacks.

Today, the COVID-19 pandemic has patently displayed inequity, and each week brings fresh accounts of how lower-income people and Black and racialized communities have been disproportionately impacted by the virus in the U.S. and Canada. This is why Gadot’s reflection in the “Imagine” video, “doesn’t matter who you are, where you’re from, we’re all in this together,” falls flat. “Imagine” is, at this moment, a drastically inappropriate choice.

Reinforcing currency

Which brings us back to Julia Roberts and #PassTheMic. When celebrities perform a modest reluctance and a generous sharing of public attention, they reinforce their own currency and importance.

By (seemingly) stepping aside, celebrities reveal their capacity to reoccupy the centres of cultural space.

Celebrity may be unserious in so many ways, but it’s worth taking our responses to it at moments like these seriously. They have much to teach us about how we are processing, however messily, crucial issues of equity and collective well-being.

Lorraine York receives funding from the Social Sciences and Humanities Research Council of Canada (SSHRC)

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending